Literature DB >> 22883813

ER stress-induced inflammation: does it aid or impede disease progression?

Abhishek D Garg1, Agnieszka Kaczmarek, Olga Krysko, Peter Vandenabeele, Dmitri V Krysko, Patrizia Agostinis.   

Abstract

Different lines of research have revealed that pathways activated by the endoplasmic reticulum (ER) stress response induce sterile inflammation. When activated, all three sensors of the unfolded protein response (UPR), PERK, IRE1, and ATF6, participate in upregulating inflammatory processes. ER stress in various cells plays an important role in the pathogenesis of several diseases, including obesity, type 2 diabetes, cancer, and intestinal bowel and airway diseases. Moreover, it has been suggested that ER stress-induced inflammation contributes substantially to disease progression. However, this generalization can be challenged at least in the case of cancer. In this review, we emphasize that ER stress can either aid or impede disease progression via inflammatory pathways depending on the cell type, disease stage, and type of ER stressor.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22883813     DOI: 10.1016/j.molmed.2012.06.010

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  154 in total

Review 1.  Emerging regulators of the inflammatory process in osteoarthritis.

Authors:  Ru Liu-Bryan; Robert Terkeltaub
Journal:  Nat Rev Rheumatol       Date:  2014-09-30       Impact factor: 20.543

Review 2.  Cellular senescence: from growth arrest to immunogenic conversion.

Authors:  D G A Burton; R G A Faragher
Journal:  Age (Dordr)       Date:  2015-03-20

Review 3.  Tipping the metabolic scales towards increased longevity in mammals.

Authors:  Celine E Riera; Andrew Dillin
Journal:  Nat Cell Biol       Date:  2015-03       Impact factor: 28.824

4.  When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157.

Authors:  Diego Rojas-Rivera; Tinneke Delvaeye; Ria Roelandt; Wim Nerinckx; Koen Augustyns; Peter Vandenabeele; Mathieu J M Bertrand
Journal:  Cell Death Differ       Date:  2017-04-28       Impact factor: 15.828

5.  Activating transcription factor 6α deficiency exacerbates oligodendrocyte death and myelin damage in immune-mediated demyelinating diseases.

Authors:  Sarrabeth Stone; Shuangchan Wu; Stephanie Jamison; Wilaiwan Durose; Jean Pierre Pallais; Wensheng Lin
Journal:  Glia       Date:  2018-02-13       Impact factor: 7.452

6.  miR-214 is Stretch-Sensitive in Aortic Valve and Inhibits Aortic Valve Calcification.

Authors:  Md Tausif Salim; Joan Fernández Esmerats; Sivakkumar Arjunon; Nicolas Villa-Roel; Robert M Nerem; Hanjoong Jo; Ajit P Yoganathan
Journal:  Ann Biomed Eng       Date:  2019-01-22       Impact factor: 3.934

7.  Activating transcription factor 3-mediated chemo-intervention with cancer chemokines in a noncanonical pathway under endoplasmic reticulum stress.

Authors:  Seong-Hwan Park; Juil Kim; Kee Hun Do; Jiyeon Park; Chang Gyu Oh; Hye Jin Choi; Bo Gyoung Song; Seung Joon Lee; Yong Sik Kim; Yuseok Moon
Journal:  J Biol Chem       Date:  2014-08-13       Impact factor: 5.157

8.  Activated macrophage-like synoviocytes are resistant to endoplasmic reticulum stress-induced apoptosis in antigen-induced arthritis.

Authors:  Li-Jie Feng; Tong-Cui Jiang; Cheng-Yue Zhou; Chang-Liang Yu; Yu-Jun Shen; Jun Li; Yu-Xian Shen
Journal:  Inflamm Res       Date:  2014-01-28       Impact factor: 4.575

Review 9.  Islet inflammation: a unifying target for diabetes treatment?

Authors:  Yumi Imai; Anca D Dobrian; Margaret A Morris; Jerry L Nadler
Journal:  Trends Endocrinol Metab       Date:  2013-02-26       Impact factor: 12.015

Review 10.  Immunogenic cell death and DAMPs in cancer therapy.

Authors:  Dmitri V Krysko; Abhishek D Garg; Agnieszka Kaczmarek; Olga Krysko; Patrizia Agostinis; Peter Vandenabeele
Journal:  Nat Rev Cancer       Date:  2012-11-15       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.